These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17449237)

  • 61. Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion.
    Sembries S; Pahl H; Stilgenbauer S; Döhner H; Schriever F
    Blood; 1999 Jan; 93(2):624-31. PubMed ID: 9885225
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia.
    Langabeer SE; Quinn F; O'Brien D; McElligott AM; Kelly J; Browne PV; Vandenberghe E
    Leuk Res; 2012 Apr; 36(4):483-4. PubMed ID: 22230299
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Candidate tumour suppressor genes at 11q23-q24 in breast cancer: evidence of alterations in PIG8, a gene involved in p53-induced apoptosis.
    Gentile M; Ahnström M; Schön F; Wingren S
    Oncogene; 2001 Nov; 20(53):7753-60. PubMed ID: 11753653
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 17p13/TP53 deletion in B-CLL patients is associated with microRNA-34a downregulation.
    Dijkstra MK; van Lom K; Tielemans D; Elstrodt F; Langerak AW; van 't Veer MB; Jongen-Lavrencic M
    Leukemia; 2009 Mar; 23(3):625-7. PubMed ID: 18818704
    [No Abstract]   [Full Text] [Related]  

  • 65. Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia.
    Auer RL; Jones C; Mullenbach RA; Syndercombe-Court D; Milligan DW; Fegan CD; Cotter FE
    Blood; 2001 Jan; 97(2):509-15. PubMed ID: 11154230
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mutational analysis of VACM-1/cul5 exons in cancer cell lines.
    Lewis SP; Willis AN; Johnson AE; Resau J; Burnatowska-Hledin MA
    APMIS; 2011 Jul; 119(7):421-30. PubMed ID: 21635549
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia.
    Mansouri L; Gunnarsson R; Sutton LA; Ameur A; Hooper SD; Mayrhofer M; Juliusson G; Isaksson A; Gyllensten U; Rosenquist R
    Am J Hematol; 2012 Jul; 87(7):737-40. PubMed ID: 22674506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Deregulation of the carbohydrate (chondroitin 4) sulfotransferase 11 (CHST11) gene in a B-cell chronic lymphocytic leukemia with a t(12;14)(q23;q32).
    Schmidt HH; Dyomin VG; Palanisamy N; Itoyama T; Nanjangud G; Pirc-Danoewinata H; Haas OA; Chaganti RS
    Oncogene; 2004 Sep; 23(41):6991-6. PubMed ID: 15273723
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.
    Stankovic T; Skowronska A
    Leuk Lymphoma; 2014 Jun; 55(6):1227-39. PubMed ID: 23906020
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Confirmation of frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukaemia.
    García-Marco JA; Navarro B; Caldas C
    Br J Haematol; 1997 Dec; 99(3):708-9. PubMed ID: 9401091
    [No Abstract]   [Full Text] [Related]  

  • 71. The class II tumor-suppressor gene RARRES3 is expressed in B cell lymphocytic leukemias and down-regulated with disease progression.
    Casanova B; de la Fuente MT; Garcia-Gila M; Sanz L; Silva A; Garcia-Marco JA; Garcia-Pardo A
    Leukemia; 2001 Oct; 15(10):1521-6. PubMed ID: 11587209
    [TBL] [Abstract][Full Text] [Related]  

  • 72. microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.
    Deneberg S; Kanduri M; Ali D; Bengtzen S; Karimi M; Qu Y; Kimby E; Mansouri L; Rosenquist R; Lennartsson A; Lehmann S
    Epigenetics; 2014 Jun; 9(6):910-7. PubMed ID: 24686393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of activation-induced cytidine deaminase mRNA levels in patients with chronic lymphocytic leukemia with different cytogenetic status.
    Gelmez MY; Teker AB; Aday AD; Yavuz AS; Soysal T; Deniz G; Aktan M
    Leuk Lymphoma; 2014 Feb; 55(2):326-30. PubMed ID: 23662991
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence-based mini-review: the role of alkylating agents in the initial treatment of chronic lymphocytic leukemia patients with the 11q deletion.
    Ding W; Ferrajoli A
    Hematology Am Soc Hematol Educ Program; 2010; 2010():90-2. PubMed ID: 21239776
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion.
    Aalto Y; El-Rifa W; Vilpo L; Ollila J; Nagy B; Vihinen M; Vilpo J; Knuutila S
    Leukemia; 2001 Nov; 15(11):1721-8. PubMed ID: 11681413
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-coding recurrent mutations in chronic lymphocytic leukaemia.
    Puente XS; Beà S; Valdés-Mas R; Villamor N; Gutiérrez-Abril J; Martín-Subero JI; Munar M; Rubio-Pérez C; Jares P; Aymerich M; Baumann T; Beekman R; Belver L; Carrio A; Castellano G; Clot G; Colado E; Colomer D; Costa D; Delgado J; Enjuanes A; Estivill X; Ferrando AA; Gelpí JL; González B; González S; González M; Gut M; Hernández-Rivas JM; López-Guerra M; Martín-García D; Navarro A; Nicolás P; Orozco M; Payer ÁR; Pinyol M; Pisano DG; Puente DA; Queirós AC; Quesada V; Romeo-Casabona CM; Royo C; Royo R; Rozman M; Russiñol N; Salaverría I; Stamatopoulos K; Stunnenberg HG; Tamborero D; Terol MJ; Valencia A; López-Bigas N; Torrents D; Gut I; López-Guillermo A; López-Otín C; Campo E
    Nature; 2015 Oct; 526(7574):519-24. PubMed ID: 26200345
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Familial chronic lymphocytic leukemia.
    Sellick GS; Catovsky D; Houlston RS
    Semin Oncol; 2006 Apr; 33(2):195-201. PubMed ID: 16616066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation.
    Di Ianni M; Baldoni S; Rosati E; Ciurnelli R; Cavalli L; Martelli MF; Marconi P; Screpanti I; Falzetti F
    Br J Haematol; 2009 Sep; 146(6):689-91. PubMed ID: 19604236
    [No Abstract]   [Full Text] [Related]  

  • 79. Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.
    Raponi S; Del Giudice I; Ilari C; Cafforio L; Messina M; Cappelli LV; Bonina S; Piciocchi A; Marinelli M; Peragine N; Mariglia P; Mauro FR; Rigolin GM; Rossi F; Bomben R; Dal Bo M; Del Poeta G; Diop F; Favini C; Rossi D; Gaidano G; Cuneo A; Gattei V; Guarini A; Foá R
    Br J Haematol; 2019 Apr; 185(1):156-159. PubMed ID: 29785734
    [No Abstract]   [Full Text] [Related]  

  • 80. Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.
    Vargas RL; Felgar RE; Rothberg PG
    J Natl Cancer Inst; 2005 Jul; 97(14):1089-90; author reply 1093-5. PubMed ID: 16030309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.